Yoo-Kang Kwak

5PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 15, 2026
Real-world outcomes of consolidative durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer: the prognostic role of clinical frailty in the post-PACIFIC era.

|Aug 29, 2024
The Clinical Course of the Late Toxicity of Definitive Radiotherapy in Cervical Cancer.

So Jung Lee, Myungsoo Kim, Yoo-Kang Kwak

|Jul 27, 2024
Predictive Factors and the Role of Conventionally Fractionated Radiation Therapy for Bone Metastasis from Renal Cell Carcinoma in the Era of Targeted Therapy.

Hye Jin Kang, Myungsoo Kim, Yoo-Kang Kwak

|Jun 27, 2024
Correction: Sung et al. Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy. Cancers 2022, 14, 3749.

Soo-Yoon Sung, Sea-Won Lee, Ji Hyung Hong

|Aug 29, 2017
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.

Yoo-Kang Kwak, Sea-Won Lee, Chul Seung Kay

Pageof 1

Frequent Collaborators

2 joint publications

Myungsoo Kim

1 joint publications

Ji Hyung Hong

1 joint publications

Ji-Hoon Kim

1 joint publications

Hye Jin Kang